ÂÜÀòÂÒÂ×

Francesca Nice is a Senior Scientist at Alchemab Therapeutics Ltd since May 2021, with extensive experience in molecular diagnostics and cancer research. Prior roles include Research Associate at the University of Cambridge's Cancer Molecular Diagnostics Laboratory, adhering to GCLP standards for DNA and RNA extraction, and Post Doctoral Scientist at the Cambridge Institute of Medical Research, focusing on the biological effects of mutations in myeloproliferative neoplasms. Francesca began research as a Graduate Research Scientist investigating acquired mutations in MPN patients to construct phylogenetic trees. Earlier experience includes a Research Scientist role at Boehringer Ingelheim, where Francesca introduced Next Generation Sequencing technologies. Francesca holds a PhD in Haematology from the University of Cambridge and a BSc in Biological and Biomedical Sciences from The University of Manchester.